Drug Discovery of COPD
COPD is one of the most common diseases in the world, and there is a global increase in prevalence, but there are no drugs available at present that halt the relentless progression of this disease. However, a better understanding of the cellular and molecular mechanisms that are involved in the underlying inflammatory and destructive processes has revealed several new targets for which drugs are now in development, and the prospects for finding new treatments are good. Lung Conferences will focus on the different techniques used in pulmonology.
- Bronchodilators
- Inhaled corticosteroids
- LABA–LAMA
Related Conference of Drug Discovery of COPD
October 12-13, 2020
International Conference on Pulmonology & Interdisciplinary Medicine
Perth, Australia
Drug Discovery of COPD Conference Speakers
Recommended Sessions
- Asthma and COPD
- Case Report
- Chronic Obstructive Pulmonary Disease
- COPD and Cardiovascular Diseases
- COPD Complications
- COPD Exacerbations
- COPD Therapeutics
- Depression and anxiety in COPD
- Drug Discovery of COPD
- Epidemiology of COPD
- Genetic risk factor of COPD
- Lung Cancer
- Pathophysiology of COPD
- Pediatric Pulmonary, Critical care and Sleep
- Pneumonia and COPD
- Pulmonary diseases-treatment and therapies
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Self-Management and Prevention of COPD
- Tuberculosis and COPD
Related Journals
Are you interested in
- Airway and Therapeutic Devices - Respiratory 2020 (Netherlands)
- Allergens and Allergies - Asthma 2020 (Portugal)
- Allergy and Immunology - Asthma 2020 (Portugal)
- Allergy Medication - Asthma 2020 (Portugal)
- Allergy Medication - PULMONARY MEET 2020 (Japan)
- Applications of probiotics in Aquaculture - Probiotics 2020 (Germany)
- Applications of Probiotics in Health and Diseases - Probiotics 2020 (Germany)
- Asthma - Asthma 2020 (Portugal)
- Asthma and allergy - Lung Diseases 2020 (South Africa)
- Asthma and allergy - copd 2020 (Japan)
- Asthma and Allergy - Lungs 2020 (France)
- Asthma and Allergy - Respiratory 2020 (Netherlands)
- Asthma and Allergy - lungdiseases 2020 (France)
- Asthma Medications - Asthma 2020 (Portugal)
- Asthma Pharmacology - Asthma 2020 (Portugal)
- Asthma Stages - Asthma 2020 (Portugal)
- Asthma Triggers - Asthma 2020 (Portugal)
- Biological effects of probiotics - Probiotics 2020 (Germany)
- Cardio Pulmonary Disorders - lungdiseases 2020 (France)
- Cardio Pulmonary Disorders - Respiratory 2020 (Netherlands)
- Cardiovascular Risk and COPD - copd 2020 (Japan)
- Chronic Bronchitis - PULMONARY MEET 2020 (Japan)
- Chronic Bronchitis & Respiratory Diseases - lungdiseases 2020 (France)
- Chronic Obstructive Pulmonary Disease - lungdiseases 2020 (France)
- Chronic Obstructive Pulmonary Disease - Lungs 2020 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2020 (Netherlands)
- CO-Morbidities in COPD - copd 2020 (Japan)
- Common Therapies of Probiotics - Probiotics 2020 (Germany)
- COPD - PULMONARY MEET 2020 (Japan)
- COPD - Asthma 2020 (Portugal)
- COPD Exacerbations - copd 2020 (Japan)
- COPD Management - copd 2020 (Japan)
- Cystic Fibrosis - PULMONARY MEET 2020 (Japan)
- Emergency Medicine - Asthma 2020 (Portugal)
- Emphysema - PULMONARY MEET 2020 (Japan)
- Environmental and Occupational lung Disease - PULMONARY MEET 2020 (Japan)
- Epidemiology of COPD - copd 2020 (Japan)
- Genomics of Probiotics and Prebiotics - Probiotics 2020 (Germany)
- Health Effects and Applications of Prebiotics - Probiotics 2020 (Germany)
- Idiopathic pulmonary fibrosis - Respiratory 2020 (Netherlands)
- Internal Medicine - Asthma 2020 (Portugal)
- Interstitial Lung Disease - Respiratory 2020 (Netherlands)
- Interstitial Lung Disease - Lung Diseases 2020 (South Africa)
- Interstitial Lung Disease - copd 2020 (Japan)
- Lung cancer - Lungs 2020 (France)
- Lung Cancer - PULMONARY MEET 2020 (Japan)
- Lung cancer - copd 2020 (Japan)
- Lung cancer - Respiratory 2020 (Netherlands)
- Lung cancer - Lung Diseases 2020 (South Africa)
- Lung Cancer: Screening, Diagnosis & Treatment - lungdiseases 2020 (France)
- Lung Disease and Respiratory Health - Lungs 2020 (France)
- Lung Diseases - copd 2020 (Japan)
- Lung Diseases - Lung Diseases 2020 (South Africa)
- Lung Infections - PULMONARY MEET 2020 (Japan)
- Lung Injury and Repair - Lungs 2020 (France)
- Lung Transplantation - lungdiseases 2020 (France)
- Lung Transplantation - Lungs 2020 (France)
- Lung Transplantation - copd 2020 (Japan)
- Lung Transplantation - Lung Diseases 2020 (South Africa)
- Lung Transplantation - Respiratory 2020 (Netherlands)
- Market strategies on Respiratory diseases - lungdiseases 2020 (France)
- Mechanisms of Probiotics - Probiotics 2020 (Germany)
- Microbiome and Probiotics - Probiotics 2020 (Germany)
- Miscellaneous - PULMONARY MEET 2020 (Japan)
- Miscellaneous - Asthma 2020 (Portugal)
- Mucosal Immune system in Lung - PULMONARY MEET 2020 (Japan)
- Mucosal Immune System in Lung - lungdiseases 2020 (France)
- Obstructive Sleep Apnea - Respiratory 2020 (Netherlands)
- Occupational & Environmental lung Disease - copd 2020 (Japan)
- Occupational & Environmental lung Disease - Lung Diseases 2020 (South Africa)
- Occupational Asthma - Asthma 2020 (Portugal)
- Occupational lung diseases - Respiratory 2020 (Netherlands)
- Paediatric lung diseases - Lungs 2020 (France)
- Paediatric Pulmonary Critical care and Sleep - lungdiseases 2020 (France)
- Paediatric Pulmonology & Critical care - Respiratory 2020 (Netherlands)
- Pathogenesis of COPD - copd 2020 (Japan)
- Pathophysiology of COPD - Lungs 2020 (France)
- Pediatric Pulmonary, Critical care and Sleep - PULMONARY MEET 2020 (Japan)
- Pediatric Pulmonology - Asthma 2020 (Portugal)
- Pleural diseases - Respiratory 2020 (Netherlands)
- Pleural Diseases - lungdiseases 2020 (France)
- Pneumonia - Respiratory 2020 (Netherlands)
- Prebiotic Foods - Probiotics 2020 (Germany)
- Prebiotics - Probiotics 2020 (Germany)
- Prevention and Control of Respiratory disease - PULMONARY MEET 2020 (Japan)
- Prevention and Control of Respiratory diseases - lungdiseases 2020 (France)
- Prevention of COPD - copd 2020 (Japan)
- Probiotic Industrial Products - Probiotics 2020 (Germany)
- Probiotic Nutrition - Probiotics 2020 (Germany)
- Probiotics - Probiotics 2020 (Germany)
- Probiotics for Animal Health - Probiotics 2020 (Germany)
- Public Health - Asthma 2020 (Portugal)
- Pulmonary Diseases and therapeutics - lungdiseases 2020 (France)
- Pulmonary diseases-treatment and therapies - Lungs 2020 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2020 (Netherlands)
- Pulmonary Hypertension - Lung Diseases 2020 (South Africa)
- Pulmonary Hypertension - Respiratory 2020 (Netherlands)
- Pulmonary Hypertension - copd 2020 (Japan)
- Pulmonary Hypertension - lungdiseases 2020 (France)
- Pulmonary Rehabilitation - lungdiseases 2020 (France)
- Pulmonary Rehabilitation - Respiratory 2020 (Netherlands)
- Pulmonary, Critical care and Sleep - Lung Diseases 2020 (South Africa)
- Pulmonary, Critical care and Sleep - copd 2020 (Japan)
- Regulatory perspectives of Probiotics and Prebiotics - Probiotics 2020 (Germany)
- Respiratory Disorders - PULMONARY MEET 2020 (Japan)
- Respiratory Equipment Devices - lungdiseases 2020 (France)
- Respiratory Infections - copd 2020 (Japan)
- Respiratory Infections - Lung Diseases 2020 (South Africa)
- Respiratory Pharmacology & Care - Lungs 2020 (France)
- Respiratory Tract Infections - PULMONARY MEET 2020 (Japan)
- Respiratory Tract Infections - lungdiseases 2020 (France)
- Strains of Probiotics - Probiotics 2020 (Germany)
- Synbiotic - Probiotics 2020 (Germany)
- The Future of Prebiotics and Probiotics - Probiotics 2020 (Germany)
- Therapeutic Devices and Evaluation - Lung Diseases 2020 (South Africa)
- Therapeutic Devices and Evaluation - copd 2020 (Japan)
- Thoracic Tumors - lungdiseases 2020 (France)
- Tuberculosis - Respiratory 2020 (Netherlands)
- Tuberculosis - lungdiseases 2020 (France)
- Tuberculosis - Lungs 2020 (France)
- Tuberculosis - PULMONARY MEET 2020 (Japan)